Clinical Trials Directory

Trials / Enrolling By Invitation

Enrolling By InvitationNCT07220330

An Investigational Study Examining the Cross-Validation of QbMobile in ADHD and Normative Populations

Status
Enrolling By Invitation
Phase
Study type
Observational
Enrollment
700 (estimated)
Sponsor
Qbtech AB · Industry
Sex
All
Age
6 Years – 60 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to investigate QbMobile ability to collect and provide accurate and objective data which can be used to facilitate assessment and treatment procedures for ADHD in a clinical setting as well as remotely.

Detailed description

This study aims to evaluate the performance of QbMobile in children, adolescents, and adults from the normative population, those referred for an initial ADHD assessment, and individuals with an ADHD diagnosis who are not currently receiving ADHD treatment. Participants will complete the 10-minute QbMobile test on their personal device during a scheduled clinical visit. They will then repeat the test remotely the following day at the same time as the previous test +/-3 hours. For participants referred for an ADHD assessment or a has an ADHD diagnosis, QbMobile must be completed prior to initiating any ADHD treatment.

Conditions

Interventions

TypeNameDescription
DEVICEQbMobileQbMobile is a software application that can be installed on a smartphone device used to measure activity, attention, impulsivity, and movement patterns in participants over a two-day period.

Timeline

Start date
2025-01-15
Primary completion
2026-10-01
Completion
2026-10-01
First posted
2025-10-23
Last updated
2025-12-31

Locations

3 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT07220330. Inclusion in this directory is not an endorsement.